TDOC
Teladoc Health·NYSE
--
--(--)
--
--(--)
TDOC fundamentals
Teladoc Health (TDOC) released its earnings on Feb 25, 2026: revenue was 642.27M (YoY +0.28%), beat estimates; EPS was -0.14 (YoY +50.00%), beat estimates.
Revenue / YoY
642.27M
+0.28%
EPS / YoY
-0.14
+50.00%
Report date
Feb 25, 2026
TDOC Earnings Call Summary for Q4,2025
- Revenue Stability: Q4 2025 revenue flat YoY at $642 million, with full-year decline of 1.5% to $2.53 billion.
- Profit Margins: Adjusted EBITDA margin of 13% in Q4, up from 11.1% full-year 2024.
- AI and Growth: Launch of Pulse AI platform to enhance clinical outcomes, with 2026 guidance for Integrated Care EBITDA margin expansion.
- BetterHelp Transformation: Insurance-based revenue targeting $75M-$90M in 2026, with session growth exceeding 1,200/day.
- Debt Management: Plans to reduce net debt through 2027 convertible debt refinancing, supporting financial flexibility.
EPS
Actual | -0.4 | -0.34 | -0.43 | -3.07 | -1.31 | -0.86 | -0.53 | -0.07 | -41.58 | -19.22 | -0.45 | -23.49 | -0.42 | -0.4 | -0.35 | -0.17 | -0.49 | -4.92 | -0.19 | -0.28 | -0.53 | -0.19 | -0.28 | -0.14 | ||||||||||
Forecast | -0.3607 | -0.2351 | -0.3217 | -0.2598 | -0.5417 | -0.5284 | -0.6719 | -0.5682 | -0.5988 | -0.611 | -0.5654 | -0.2459 | -0.4841 | -0.4065 | -0.3645 | -0.2193 | -0.4586 | -0.3446 | -0.277 | -0.2616 | -0.3386 | -0.2579 | -0.2636 | -0.1793 | ||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -10.90% | -44.62% | -33.66% | -1081.68% | -141.83% | -62.76% | +21.12% | +87.68% | -6843.89% | -3045.66% | +20.41% | -9452.66% | +13.24% | +1.60% | +3.98% | +22.48% | -6.85% | -1327.74% | +31.41% | -7.03% | -56.53% | +26.33% | -6.22% | +21.92% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 180.80M | 241.03M | 288.81M | 383.32M | 453.68M | 503.14M | 521.66M | 554.24M | 565.40M | 592.38M | 611.40M | 637.71M | 629.24M | 652.41M | 660.24M | 660.53M | 646.13M | 642.44M | 640.51M | 640.49M | 629.37M | 631.90M | 626.44M | 642.27M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 178.46M | 220.67M | 282.18M | 378.93M | 451.91M | 500.60M | 516.63M | 547.17M | 568.68M | 586.74M | 608.89M | 633.40M | 619.30M | 649.18M | 663.54M | 670.81M | 637.31M | 649.16M | 631.18M | 639.55M | 619.20M | 622.54M | 625.76M | 635.31M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +1.31% | +9.22% | +2.35% | +1.16% | +0.39% | +0.51% | +0.97% | +1.29% | -0.58% | +0.96% | +0.41% | +0.68% | +1.61% | +0.50% | -0.50% | -1.53% | +1.38% | -1.03% | +1.48% | +0.15% | +1.64% | +1.50% | +0.11% | +1.09% |
Earnings Call
You can ask Aime
What were the key takeaways from Teladoc Health's earnings call?What is the market's earnings forecast for Teladoc Health next quarter?What is Teladoc Health's latest dividend and current dividend yield?Did Teladoc Health beat or miss consensus estimates last quarter?What does Teladoc Health do and what are its main business segments?What is Teladoc Health's gross profit margin?What is the revenue and EPS growth rate for Teladoc Health year over year?What guidance did Teladoc Health's management provide for the next earnings period?
